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ABSTRACT
Background: Dengue fever persists as a major global disease burden, and may increase as
a consequence of climate change. Along with other measures, research actions to improve
diagnosis, surveillance, prevention, and predictive models are highly relevant. The European
Commission funded the DengueTools consortium to lead a major initiative in these areas, and
this review synthesises the outputs and findings of this work conducted from 2011 to 2016.
Research areas: DengueTools organised its work into three research areas, namely [1] Early
warning and surveillance systems; [2] Strategies to prevent dengue in children; and [3]
Predictive models for the global spread of dengue.
Research area 1 focused on case-studies undertaken in Sri Lanka, including developing
laboratory-based sentinel surveillance, evaluating economic impact, identifying drivers of
transmission intensity, evaluating outbreak prediction capacity and developing diagnostic
capacity. Research area 2 addressed preventing dengue transmission in school children, with
case-studies undertaken in Thailand. Insecticide-treated school uniforms represented an
intriguing potential approach, with some encouraging results, but which were overshadowed
by a lack of persistence of insecticide on the uniforms with repeated washing. Research area 3
evaluated potential global spread of dengue, particularly into dengue-naïve areas such as
Europe. The role of international travel, changing boundaries of vectors, developing models
of vectorial capacity under different climate change scenarios and strategies for vector
control in outbreaks was all evaluated.
Concluding remarks: DengueTools was able to make significant advances in methods for
understanding and controlling dengue transmission in a range of settings. These will have
implications for public health agendas to counteract dengue, including vaccination
programmes.
Outlook: Towards the end of the DengueTools project, Zika virus emerged as an unexpected
epidemic in the central and southern America. Given the similarities between the dengue and
Zika viruses, with vectors in common, some of the DengueTools thinking translated readily
into the Zika situation.
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Background
Despite the increasing global burden of dengue both in
terms of annual incidence and geographic distribution
[1,2], dengue remains a neglected disease [3]. In 2010,
the European Commission launched a Seventh
Framework Programme call entitled ‘Comprehensive
control of dengue under changing climatic
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conditions’. In response, scientists from 14 institutions
in Europe, Asia, and South America formed the
“DengueTools” consortium. DengueTools was
awarded a grant in 2011, together with two other
dengue research consortia (IDAMS and DENFREE)
[4]. DengueTools’ objectives were to achieve better
diagnosis, surveillance, prevention, and predictive
models and improve our understanding of the spread
of dengue to previously uninfected regions (including
Europe) in the context of globalisation and climate
change. The consortium comprised 12 work packages
to address research objectives in three main areas:
● Research area 1: Early warning and surveillance
systems.
● Research area 2: Strategies to prevent dengue in
children.
● Research area 3: Predictive models for the global
spread of dengue, in particular the risk of intro-
duction and establishment in Europe.
The composition of the consortium including its
institutional geography, work packages and research
design are outlined in detail in the DengueTools
study design paper from 2012 [5]. Here, in compli-
ance with accountability and transparency on best use
of European Commission research funding, we
synthesise the main research findings and publica-
tions from the five-year DengueTools research
project.
Research area 1
Overall objective: Develop a comprehensive, early
warning, surveillance system that has predictive cap-
ability for epidemic dengue and benefits from novel
tools for laboratory diagnosis and vector monitoring
Rationale: The dramatic global spread and
increased frequency and magnitude of epidemic den-
gue in the past 50 years underscores the critical need
for more effective surveillance, including better tools.
Specific objectives
Develop a laboratory-based sentinel disease
surveillance system in Sri Lanka
Dengue poses a significant disease burden in Sri
Lanka [6]. Historically surveillance was passive, with
mandatory dengue notifications based on clinical
diagnosis and limited laboratory confirmation. With
DengueTools funds, we established laboratory-based
enhanced sentinel surveillance in Colombo District
[7]. Three outpatient clinics and three government
hospitals from the Colombo metropolitan area were
selected. We enrolled 3,127 febrile cases, and found
that 44% were PCR and/or NS1 positive for dengue
(of which 54% were inpatients and 7.6% in
outpatients). Dengue serotype 1 (DENV-1) was
responsible for 85% of the cases and serotype 4
(DENV-4) for 15%. The incidence of severe dengue
in those hospitalised was 22%, with a case fatality rate
of 0.9% in those presenting with severe dengue. The
case fatality rate in the cohort was below 0.1%.
The emergence of DENV-1 as the foremost ser-
otype highlights the changing epidemiology of den-
gue and the need for continued surveillance and
prevention [8]. DENV-4 infections are globally less
common, and also infrequent in Sri Lanka. As
about 15% of our population had a DENV-4 infec-
tion, to better understand the molecular epidemiol-
ogy of DENV-4 infections in Sri Lanka, we
conducted whole-genome sequencing on dengue
patient samples from two different geographic loca-
tions, showing the DENV-4 strains belonged to
genotype 1, most closely related to those circulating
in India and Pakistan [9].
We also explored internet-based media coverage in
Sri Lanka to assess whether internet hits would cor-
relate with dengue activity. Digital media coverage for
dengue was far higher than for other infectious dis-
eases and highly correlated with national epidemio-
logical trends in dengue [10]. Our findings underpin
previous claims that digital media reports of dengue
reflect national epidemiological trends, both annually
and in inter-annual seasonal variations, thus acting as
proxy bio-surveillance to provide early warning and
situation awareness.
Evaluate the economic impact of dengue
In Sri Lanka, the continuous involvement of large num-
bers of public health personnel in dengue control and the
provision of free medical care to dengue patients place
a formidable financial burden on the Ministry of Health.
We retrospectively estimated the public sector costs of
dengue control and hospitalisations in Colombo district.
In the epidemic year of 2012, the total cost was estimated
at US$3.45million (US$1.50 per capita), of whichUS$.42
was for control. Personnel costs accounted 79% of den-
gue control and 46% of hospitalisations [11]. Average
costs per hospitalisation ranged between US$216–609
and US$196–866 per paediatric and adult patient respec-
tively, by disease severity and treatment setting. Country-
specific evidence on the economic burden of dengue is
important to set public health priorities and decide about
deploying existing or new technologies.
Investigate socio-behavioural, entomological and
environmental indicators that drive dengue
transmission intensity in Sri Lanka
To assess Aedes mosquito breeding sites and prevention
practices of community members, we conducted a cross-
sectional entomological survey in 1,469 premises (1,341
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households, 11 schools, 99 work or public sites, 5 open
lands, and 13 non-specified) located in a sub-district of
Colombo [12]. Types of breeding sites and infestation
with larvae or pupae were recorded. A questionnaire on
dengue vector control practices was administered to
occupants. Schools had a higher proportion of productive
sites (64%) than households (15%). The odds ratio (OR)
for productive breeding sites was 2.77 (95%CI 1.58–4.86)
for schools andother non-residential buildings compared
to residences. Residential occupants were more likely to
take preventive measures. These findings emphasise the
need to expand public health strategies to schools and
other non-residential premises.
Evaluate the outbreak prediction capability of
weather in Sri Lanka
Understanding the drivers of dengue is vital in con-
trolling and preventing the disease spread. Weekly
weather and dengue data, measured in 10 divisions
in Kalutara, a district in Sri Lanka were retrieved and
analysed [13]. Distributed lag non-linear time series
analysis was used to estimate division-specific risks,
and hierarchical models were fitted to estimate the
overall relationships between el Niño conditions,
weather and dengue across divisions. A clear relation-
ship was observed between Oceanic Nino Index
(ONI) and dengue in Kalutara district, Sri Lanka,
with a peak effect at 6 months. The pattern between
ONI and dengue incidence was mediated by rainfall
and temperature. Consistent exposure-response pat-
terns between different geographical locations were
observed for rainfall, showing increasing relative risks
of dengue with increasing rainfall from 50 mm per
week, with the highest risk 6 to 10 weeks after rain-
falls of more than 300 mm per week. The overall
relative risk of dengue associated with temperature
increased steadily from lower temperatures towards
the mean value of 29.8°C, starting from a lag of
4 weeks, and increased for temperatures above the
mean value with a cumulative growing association
with lags up to 12 weeks.
Develop and validate novel diagnostic assays for
point-of-care use
Diagnostics for dengue is challenging without afford-
able, sensitive and specific point-of-care testing [14].
We developed a prototype reverse transcription-
recombinase polymerase amplification (RT-RPA)
assay that is quick and can be undertaken in low
resource settings [15]. The RPA is an isothermal
nucleic acid amplification technology where reactions
take place at a low and constant temperature between
22°C and 45°C [16]. Fluorescence was detected using
a portable real-time fluorometer, ‘Twista®’, which has
a small footprint and can be rendered entirely
portable with the addition of a rechargeable battery
pack, developed by the private sector collaborator,
TwistDx.
The assay detected as few as 10 copies of DENV
RNA within 20 minutes without the need for thermo-
cycling amplification. The RT-RPA assay is the most
rapid molecular diagnostic tool available for the detec-
tion of DENV. The RT-RPA assay showed good con-
cordance (κ = 0.723) with the RT-LAMP and qRT-PCR
assays in detecting DENV in viraemic samples [17].
When evaluated for effectiveness and efficiency among
new users, the user satisfaction towards the RT-RPA
protocol and interpretation of results were 100% and
90%, respectively [18]. Though the RPA requires use of
the TwistDx equipment, the RPA is simple, affordable,
user-friendly, and independent of outside temperature,
rendering it suitable for field-use.
Develop novel assays for virus detection and
characterisation in aedes mosquitoes
Viral detection in Aedes mosquitoes is often difficult,
especially for small amounts of DENV in batches of
mosquitoes from dengue surveillance. We developed
a new polymerase chain displacement reaction
(PCDR), which uses multiple nested primers in
a rapid, capped, one-tube reaction that increases the
sensitivity of normal quantitative PCR (qPCR) assays
[19]. Sensitivity increased approximately 10-fold.
Increased sensitivity will be useful in nucleic acid
detection for viral diagnostics, and can enhance
virus detection in vector surveillance.
Research area 2
Overall objective: Develop novel tools for the preven-
tion of dengue in school-aged children
Rationale: Compliance with personal protective
measures such as insect repellents [20] are low
[21]. Wolbachia-infected mosquitoes or genetically
modified male mosquitoes appear promising
[22,23], but their use remains controversial and
large-scale implementations are unlikely in the
near future. Hence, there is an urgent need for
timely scalable solutions. Since Aedes aegypti is
a day-biting mosquito, developing technologies
that offer daytime protection against mosquito
bites is essential. Permethrin is a pyrethroid-
based insecticide registered by the US
Environmental Protection Agency since 1977 that
has been extensively used as an insect repellent
and insecticide with a documented safety record
[24]. Permethrin can be bound to fabric fibres in
clothing via different techniques such as micro-
encapsulation and polymer coating [25,26].
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Specific objectives
Review literature on protective efficacy of
insecticide-treated clothing against vector-borne
diseases
Insecticide-treated clothing has been used for many
years by the military and in recreational activities as
personal protection against bites from a variety of
arthropods including ticks, chigger mites, sandflies
and mosquitoes and is thought to be safe [24]. We
reviewed the evidence base for its use against bites
from arthropods and its effect on arthropod-borne
pathogen transmission. Insecticide-treated clothing
has been reported to provide between 0% and 75%
protection against malaria and between 0% and 79%
protection against leishmaniasis [24]. No field trials
had been conducted to demonstrate the efficacy
against Aedes-transmitted diseases. However, one
study showed that wearing permethrin-treated cloth-
ing resulted in a reduction in the number of Aedes
bites by 90% [27] suggesting that it could potentially
be a promising intervention for Aedes-transmitted
diseases such as dengue.
Determine the efficacy of insecticide-treated
school uniforms (isus) under different laboratory
scenarios
Here we assessed the efficacy and durability of different
types of ISUs on laboratory-reared Aedes aegypti [28].
Standardised World Health Organization Pesticide
Evaluation Scheme (WHOPES) cone tests were used
to assess knockdown (KD) and mortality of Aedes
aegypti tested against factory-treated fabric, home-
dipped fabric and microencapsulated fabric. The stan-
dardised cone test is used to assess the effectiveness of
an insecticide and its persistence onmaterials, following
the WHO protocol. This test aims to compare the
behaviour of mosquitoes while in contact with treated
mosquito nets. We found InsectShield®-treated fabric
achieved the highest KD and mosquito mortality, and
decided to use InsectShield® for the school-based ran-
domised controlled trial.
In arm-in-cage experiments whereby volunteers
hold their arm in cages for starved laboratory bred
Aedes mosquitoes to feed on showed that ISUs reduced
landing by 58.9% and biting by 28.5% [29]. We assessed
the effect of washing on treated clothing, skin coverage
and protection against resistant and susceptible Aedes
aegypti using modified WHO arm-in-cage assays.
Coverage was further assessed using free-flight room
tests to investigate the protective efficacy of unwashed
factory-treated clothing. Clothing was worn as full cov-
erage (long sleeves and trousers) and partial coverage
(short sleeves and shorts). In the arm-in-cage assays,
unwashed clothing reduced landing by 58.9% and bit-
ing by 28.5% [29]. Landing and biting for resistant and
susceptible strains was not significantly different. In
free-flight room tests, full coverage treated clothing
reduced landing by 24.3% and biting by 91% with
partial coverage reducing landing and biting by 26.4%
and 49.3% respectively, thus coverage type made no
significant difference on landing [29]. Whilst ISUs
with long sleeves and trousers provided the highest
form of protection, partially covering the body with
permethrin-treated clothing did provide significant
protection against biting.
Model the potential impact of isus on reducing
dengue incidence
Mathematical models [30] were used to calculate the
risk of dengue infection based on force of infection,
taking into account the estimated proportion of mos-
quito bites that occur in school and the proportion of
school time that children wear ISUs, plus the findings
from our laboratory studies on the impact of reduction
on mosquito bites [29]. We modelled the use of ISUs as
having an efficacy varying from around 6% in the most
pessimistic estimations, to 55% in the most optimistic
scenarios simulated. The efficacy of ISUs would depend
on the compliance of the target population in terms of
proper and consistent wearing of ISUs.
Conduct a school-based randomised controlled
trial to assess the efficacy of isus on the reduction
of dengue incidence in school-aged children in
Thailand
As children spend a considerable amount of their day
at schools, strategies that reduce human–mosquito
contact to protect against day-biting Aedes mosqui-
toes could be effective. Most schools in dengue ende-
mic countries require school uniforms. We
hypothesised that ISUs might reduce dengue infec-
tions [31]. We tested our hypothesis by setting up
a large community-based trial to determine the
reduction of dengue infections due to ISUs
(InsectShield®) [32].
We ran a blinded trial over a school term
(5 months) in 10 schools in Thailand (5 intervention
and 5 control) [33]. The primary endpoint was
laboratory-confirmed dengue infections. We also
included as secondary endpoints 1-hour knock-
down and 24 hour mosquito mortality on ISUs mea-
sured by standardised WHOPES bioassay cone tests
at baseline and after repeated washing. Entomological
assessments were done inside classrooms and in
school environments.
Paired serum samples were obtained from 1,655
pupils [33]. We did not find a significant difference in
proportions of students having incident dengue infec-
tions between the intervention and control schools,
allowing for clustering by school. WHOPES cone
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tests showed a 100% knock down and mortality of
Aedes aegypti mosquitoes exposed to impregnated
clothing at baseline and up to 4 washes, but this
efficacy rapidly declined to below 20% after 20
washes. Results of the entomological assessments
showed that the mean number of Aedes aegypti mos-
quitoes caught inside the classrooms of the interven-
tion schools was significantly reduced in the month
following the introduction of the impregnated uni-
forms, compared to those collected in classrooms of
the control schools, but there were no differences in
the subsequent months.
Assess the acceptability of ISUs
Using a mixed method approach with qualitative and
quantitative approaches to survey Thai parents, we
found that the acceptability of ISUs was high. Most
parents (87.3%; 95% CI 82.9–90.8) would allow chil-
dren to wear ISUs and 59.9% (95% CI 53.7–65.9) of
parents would accept additional costs for ISUs over
normal uniforms, should ISUs be shown to be effec-
tive against mosquito bites and reduction of den-
gue [34].
Develop a cost-effectiveness framework and
model for school-based preventive interventions
using isus
We investigated the cost-effectiveness of using ISUs
for population-based dengue prevention in school-
aged children under various scenarios of intervention
effectiveness and cost and dengue infection risk,
using data specific to Thailand. At an average inci-
dence rate of 5.8% per year, the intervention proved
cost-effective (cost per disability-adjusted life-year
averted ≤$16,440) when the intervention cost per
child per year was $5.30 or less and the intervention
effectiveness was 50% or higher, and cost saving in all
scenarios in which the cost was $2.90 or less and the
effectiveness was 50% or higher [35]. The interven-
tion would be of no interest to Thai policy makers if
the per-child cost were $10.60 or higher per year
regardless of its effectiveness.
Research area 3
Overall objective: Explore reasons for the spread of
dengue, in particular the risk of introduction and
establishment in Europe, within the context of vec-
torial capacity, human mobility, and climate
change, using predictive models.
Rationale: Long-term climate change and weather
variability affect the proliferation of Aedes mosquitoes.
Furthermore, air travel between dengue-endemic coun-
tries and from dengue-endemic to non-endemic vul-
nerable settings has increased exponentially [36].
Whilst imported dengue cases to the US have resulted
in small dengue clusters for many years [37], the first
sporadic autochthonous cases in Europe (France and
Croatia) were reported in 2010 [38,39]. In 2012, the first
major European outbreak of dengue occurred in
Madeira [40]. International travellers are increasingly
at risk of dengue [2,41–44], with attack rates reported as
high as 5.51 cases per 1,000 travel-months to endemic
areas [45]. Dengue is now the leading cause of fever in
returning travellers, having overtaken malaria for tra-
vellers to South East Asia [46].
Specific objectives
Describe dengue importations into dengue-naïve
countries (with a focus on Europe)
Between 6–87% of travellers become ill during travel
[47]. Sentinel surveillance can aid to estimate the
burden of disease in travellers [48–54] despite the
lack of a denominator [55]. We conducted sentinel
surveillance in travellers returning to Europe through
travel medicine providers from TropNet. TropNet is
a European Network on Imported Infectious Disease
Surveillance that conducts sentinel surveillance in ill-
returned travellers seen by travel medicine providers
of the network. Our sentinel surveillance system
included 242 returning dengue viraemic travellers;
corresponding to 36% of all returning travellers with
dengue. Consequently, a significant number of virae-
mic dengue-infected travellers return to Europe,
underpinning the potential for the introduction of
dengue viruses into dengue-naïve areas [56]. The
most likely place for acquiring dengue was Asia,
followed by the Americas, then Western Pacific
region, and the smallest number from Africa [57].
First, we detected circulation of DENV-3 (geno-
type III) in Cuba in 2013 and 2014, despite the fact
that PAHO did not report any dengue during that
time period. The last detection of that genotype in
Cuba was during a big epidemic occurring in
2001–2002 (unpublished data). Second, we isolated
a DENV-3 strain from a traveller returning from
Togo and Burkina Faso, both countries where circu-
lation of dengue had not been reported, highlighting
that travellers can unmask ongoing transmission. We
also identified a dengue virus strain from Angola in
2013 unmasking a new outbreak in that country [58].
Third, virus isolates obtained from travellers who had
acquired dengue in Madeira, Portugal, were
sequenced and found to be genetically linked to
virus isolates from Brazil and Venezuela [40,59]. We
developed an importation index that takes into
account both travel volume and the extent of dengue
incidence in Brazil and Venezuela which pointed
towards Venezuela being the source of importation
[60]. Fourth, DENV-1 (genotype I, Asian) was
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isolated from a traveller returning from Japan during
Tokyo’s first dengue outbreak of about160 auto-
chthonous cases in August-September 2014.
Investigating the origin of the Japanese outbreak,
sequencing suggested that this virus may have been
imported from China, Indonesia, Singapore, or
Vietnam [61]. Based on importation modelling,
China was identified to be the most likely source [61].
Model dengue virus introductions via travellers
To estimate the risk of travellers introducing dengue,
travel volume, incidence of dengue in the country of
disembarkation, probability of being infected at the
time of travel and duration of viraemia need to be
taken into account. We developed mathematical mod-
els for the risk of introducing dengue into dengue
naïve areas [62]. These models were applied to various
situations: risk of importation of dengue into Italy [63]
given the presence of susceptible Aedes populations
that allowed an outbreak of chikungunya to occur in
2007 [64]; the risk from non-immune persons travel-
ling to Thailand [65]; and to other infectious diseases
such as polio [66,67] and Zika [68,69].
The mathematical modelling was also applied to
estimate the number of dengue-viraemic air passen-
gers from the main dengue-endemic countries enter-
ing Europe. Our models estimate a range of zero to
167 dengue-viraemic air passengers entering the 27
receiving countries in one year, with Germany receiv-
ing the highest number followed by France and the
UK [70]. Modelling the number of importations, the
presence of suitable mosquito populations and vec-
torial capacity, the risk of onward transmission in
Europe is reassuringly low [70].
Model vectorial capacity for aedes mosquitoes
in temperate climate zones and globally under
current and future climate scenarios
Vectorial capacity describes a vector’s propensity to
transmit dengue taking into account human, virus,
and vector interactions. Recent evidence shows that
diurnal temperature range (DTR) plays an important
role in influencing Aedes vector competence. In these
studies, we developed predictive models of vectorial
capacity for Ae. aegypti and Ae. albopictus [71,72],
ability to transmit dengue in relation to temperature
and diurnal temperature variability. We found strong
temperature dependent dengue epidemic potential,
with optimal transmission around a constant tem-
perature of 29⁰C, with vectorial capacity decreasing
at higher temperatures. This decline was partly offset
when diurnal temperature range was larger, with at
least part of the day reaching near-optimal conditions
[71,72]. Incorporating these findings using historical
and predicted temperature and DTR over 200 years
(1901–2099), there was an increasing trend in dengue
epidemic potential in temperate regions. Future
changes depend considerably on the current and
future carbon emissions. Southern Europe is at risk
of increasing seasonal dengue transmission windows
in future climate change scenarios.
Assess efficacy of ULV and thermal aerosols of
deltamethrin for control of aedes albopictus in
Europe
Ultra-low volume (ULV) insecticidal aerosols dis-
pensed from vehicle-mounted cold-foggers are widely
considered the method of choice for control of Ae.
aegypti and Ae. albopictus Nevertheless, their effec-
tiveness has been poorly studied, particularly in
Europe. We evaluated the efficiency of the two widely
used space spraying methods to control Ae. albopictus
and Ae. aegypti in France, and found hand-held ther-
mal foggers to be more effective than ULV [73].
Develop geo-spatial modelling and risk maps
A systematic literature review was undertaken to
study predictors and modelling approaches used to
create dengue risk maps [74]. The relevant predictors
among demographic and socio-economic variables
were age, gender, education, housing conditions and
level of income. Among environmental variables, pre-
cipitation and air temperature were often significant
predictors. Descriptive maps showing dengue case
hotspots were useful for identifying high-risk areas.
Predictive maps based on more complex methodol-
ogy facilitated advanced data analysis and visualisa-
tion. No specific patterns were identified in the
combination of predictors or models across studies.
Explore the contribution of urbanisation to
dengue transmission
Globalisation with increasing interconnectivity, eco-
logical habitat encroachment, socioeconomic
changes, climate change, virus evolution, and urbani-
sation all drive dengue transmission intensity [75].
We studied the relative contributions of putative dri-
vers for the rise of dengue in Singapore: population
growth, climate parameters and international air pas-
senger arrivals from dengue endemic countries, from
1974 to 2011 [76]. Estimating the extent of the con-
tribution of three factors (population growth versus
weather variability versus air passenger arrivals into
Singapore) on the increasing dengue incidence, we
found that population growth contributed to 86%
while the residual 14% was explained by increase in
temperature. No correlation was found with incom-
ing air passenger arrivals into Singapore from dengue
endemic countries.
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Concluding remarks
As a result of the EU funded laboratory-enhanced
surveillance project for laboratory capacity building,
a dedicated government laboratory in Sri Lanka was
set up to perform routine molecular testing for den-
gue which operated sustainably after the funding
period. Quality assurance with a subset of samples
sent to the Duke-NUS Laboratory ‘Emerging
Infectious Diseases Program’ showed high agreement
[7]. The improved RT-RPA as a rapid assay for den-
gue diagnosis is now routinely used for detection of
DENV at the WHO Collaborating Center for
Arbovirus Reference and Research (Dengue/Severe
Dengue) at the University of Malay.
Given the day-biting behaviour of Aedes mosqui-
toes, ISUs could potentially be a novel tool to reduce
mosquito-borne diseases and local vector popula-
tions. Our results from the WHOPES cone tests
underpin the potential for ISUs to protect against
dengue by reducing the populations of Aedes mos-
quitoes and hence mosquito-bites: knock-down effect
and mortality immediately after impregnation of uni-
forms with permethrin by the InsectShield® proprie-
tary method were close to 100% [33], consistent with
results obtained under laboratory conditions [28].
Furthermore, we documented a significant reduction
in Aedes mosquito numbers in the classrooms of the
intervention schools in the first month after the start
of the trial at the time when the insecticidal activity of
impregnated uniforms was still 100%.
However, our cluster-randomised controlled trial
in ten Thai schools involving 1,811 children did not
show serological evidence of a protective effect over
the 5-month study period. This negative result was
probably due to the rapidly waning efficacy of
InsectShield® ISUs under field conditions. After 20
washes, the knock-down and mortality effects on
mosquitoes were well below 20%. Long-lasting insec-
ticide-treated bed-nets were a major breakthrough in
the control of malaria. However, bed-nets do not get
washed so frequently. For ISUs to be a viable public
health intervention they must withstand regular
washing. If the rapid washing-out of permethrin can
be overcome by novel technological approaches, ISUs
would deserve to be re-evaluated as a potentially cost-
effective and scalable intervention [33].
Both the questionnaire survey in Sri Lanka [12] and
clustering analyses in Thailand [77] found that schools
are high-risk locations for dengue transmission,
underpinning the urgent need to implement vector
control strategies at schools, while maintaining house-
hold efforts.
Many unknowns, including effective entomologi-
cal predictors, genetic diversity of circulating viruses,
population serological profile, and human mobility
still limit the ability to produce accurate and effective
risk maps, and impede the development of early
warning systems [74]. However, our newly developed
mathematical models and vectorial capacity calcula-
tions serve as additional tools to assist to predict the
risk of importation and potential for establishment in
dengue naïve areas.
Under various climate change scenarios, seasonal
peaks and time windows for dengue epidemic poten-
tial will increase during the 21st century in Europe.
We mapped dengue epidemic potential in Europe
and identified seasonal time windows when major
cities are most at risk of dengue transmission from
1901 to 2099 [71]. Our findings illustrate, that besides
vector control, mitigating greenhouse gas emissions
crucially reduces the future epidemic potential of
dengue in Europe. Much still needs to be learned
about the impact of climate on dengue transmission.
Models also showed that population growth is the
main driver for dengue resurgence in Singapore [76].
These findings have significant implications for pre-
dicting future trends of the dengue epidemics given
the rapid urbanisation with population growth in
many dengue endemic countries. It is time for policy-
makers and the scientific community alike to pay
more attention to the negative impact of urbanisation
and urban climate on diseases such as dengue.
Increasing dengue burdens and risks justify dengue
vaccination. Our literature review showed that coun-
try-level analytical expertise in economic analyses
needs to be strengthened to facilitate evidence-based
decision-making on dengue vaccine introduction in
endemic countries [78]. After decades of research the
first dengue vaccine is now licensed, but, because the
vaccine’s performance depends on serostatus, massive
programmatic role out will be difficult [79,80]. The
long-term safety follow up in the Phase 3 trials showed
that the vaccine was efficacious and safe in those
individuals who were seropositive at the time of vacci-
nation, eg who had a previous dengue infection, but
the vaccine increased the risk of severe dengue in those
who were seronegative. On the basis of these new long-
term safety data of the Phase 3 trials, WHO now
recommends pre-vaccination screening for serosta-
tus [79].
Complementing the development of methods and
tools for dengue control, efforts were undertaken to
disseminate products and findings. We conducted
collaborative workshops with other dengue projects
and organised seminars in different partner institu-
tions. Many Masters and PhD students were trained
as part of capacity building in research conduct and
methodology, especially from low- and middle-
income partner countries. A grand-finale dissemina-
tion event on dengue and dengue haemorrhagic fever
was organised in conjunction with the Ministry of
Health of Sri Lanka in Colombo, in February 2016,
attended by local, regional and international health
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professionals. Further information is available at
www.denguetools.com.
Detailed findings from DengueTools are presented
in 47 peer-reviewed scientific publications, as listed in
a Supplementary File. Moreover, Box 1 summarises
DengueTools’ key deliverables.
Despite of global efforts the global scientific commu-
nity still fails to stem the tide of dengue worldwide as
dengue relentlessly continues to increase in incidence.
Many research gaps still exist that the DengueTools
consortium was not able to address. More implementa-
tion research, improved vaccines and vector control
measures are needed to turn the tide.
Outlook
Towards the end of DengueTools project funding,
Zika virus (ZIKV) emerged as a new public health
threat [81]. Given ZIKV`s relatedness to dengue
viruses and its common vector, the European
Commission asked us to extend our research to
include ZIKV in the remaining months of our funded
project time. Due to our expertise related to mathe-
matical modelling, and vectorial capacity – developed
through DengueTools – we decided to focus our
research in this area. As ZIKV was rapidly spread
via travellers [82–87], we modelled the risk of ZIKV
importations from Brazil into Europe [69,88]. We
analysed and overlaid the monthly flows of airline
travellers arriving into European cities from Zika
affected areas across the Americas, and the predicted
monthly estimates of the basic reproduction number
of Zika virus in areas where Aedes mosquito popula-
tions reside in Europe. Based on these analyses, we
highlighted specific geographic areas and timing of
risk for Zika virus introduction and possible spread
within Europe to inform the efficient use of human
disease surveillance, vector surveillance and control,
and public education resources [89].
Furthermore, we modelled the timing and origin
of ZIKV introduction into Brazil. Based on the force
of infection in French Polynesia (where ZIKV caused
an outbreak in 2014), ZIKV basic reproduction num-
ber in selected Brazilian cities, and estimated travel
volume, we concluded that ZIKV was most likely
introduced and established in Brazil by infected tra-
vellers arriving from French Polynesia in the period
between October 2013 and March 2014 [90].
In 2016, the World Health Organization sought
advice on whether ZIKV would be a risk at the
upcoming Olympics in Brazil. We modelled the risk
as not substantial [68,91,92] and advocated that the
Olympics should not be cancelled. Subsequently, the
virtual absence of ZIKV cases during the Olympics
confirmed our predictive modelling.
When in early 2016, the European Commission
launched a call for Zika research under Horizon
2020 Research and Innovation Programme, many of
the DengueTools members together with new part-
ners from Latin America assembled yet again to
respond to the call under the consortium name
‘ZikaPLAN’. ZikaPLAN (grant agreement n°
734,584) was awarded €11.6 M in October 2016, as
described elsewhere [93].
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